Clinical Trials
2
Active:0
Completed:1
Trial Phases
2 Phases
Phase 1:1
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (50.0%)Phase 2
1 (50.0%)Study of the Oral Treatment MTR-601 in Cervical Dystonia
- First Posted Date
- 2025-02-17
- Last Posted Date
- 2025-10-20
- Lead Sponsor
- Motric Bio
- Target Recruit Count
- 80
- Registration Number
- NCT06830642
- Locations
- 🇺🇸
CenExel Rocky Mountain Clinical Research, Englewood, Colorado, United States
🇺🇸Rush University Medical Center, Chicago, Illinois, United States
🇺🇸Massachusetts General Hospital, Boston, Massachusetts, United States
Single and Multiple Ascending Dose Study of MTR-601 in Healthy Individuals
Phase 1
Completed
- Conditions
- Multiple SclerosisSpinal Cord InjuriesCerebral PalsyStrokeDystoniaHypertonia, MuscleMuscle SpasticityHereditary Spastic Paraplegia
- Interventions
- First Posted Date
- 2023-11-03
- Last Posted Date
- 2025-03-12
- Lead Sponsor
- Motric Bio
- Target Recruit Count
- 89
- Registration Number
- NCT06117020
- Locations
- 🇺🇸
Worldwide Clinical Trials, San Antonio, Texas, United States
News
No news found